EconPapers    
Economics at your fingertips  
 

Biopharmaceuticals in Latin America: challenges and opportunities

Jorge Niosi (), Tomas Bas () and Julieta Flores Amador

Innovation and Development, 2013, vol. 3, issue 1, 19-36

Abstract: This paper is about catching up in human health biotechnology. It analyses biotechnology publication and patents and conducted interviews with academics and company executives in several countries. Some 60 interviews conducted in the three countries made clear that public support for biotechnology in the region is low when compared with OECD and emerging Asian countries. Yet, some companies built successful independent business models in the region. This paper is focused on the three countries that have the largest pharmaceutical industry in Latin America (LA): Argentina, Brazil, and Mexico. These countries are suppliers for the whole region and are exporting medicines outside the region. All three countries are net drug importers, but local laboratories represent a substantial share of their domestic markets. The pharmaceutical industry is experiencing a radical organizational shift, namely the merging of the innovative and generic pharmaceuticals and dedicated biotechnology models. Such change may help these emerging countries to increase their innovative capabilities. To further such industrial catching up would require increased investments by LA national governments in both public- and private-sector research.

Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://hdl.handle.net/10.1080/2157930X.2012.760899 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:riadxx:v:3:y:2013:i:1:p:19-36

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/riad20

DOI: 10.1080/2157930X.2012.760899

Access Statistics for this article

Innovation and Development is currently edited by K J Joseph (Editor-in-chief), Cristina Chaminade, Gabriela Dutrénit, Judith Sutz, Tim Turpin and Susan Cozzens

More articles in Innovation and Development from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().

 
Page updated 2025-03-20
Handle: RePEc:taf:riadxx:v:3:y:2013:i:1:p:19-36